SEP 15, 2016 4:03 AM PDT

Smart Drugs May Become Harder to Get

In January of 2016, a law enacted in the UK changed the landscape of the market for “smart drugs” known as “nootropics.”  They are not prescription drugs, but rather over the counter supplements and formulations of different herbs, minerals and ingredients marketed as cognitive enhancing. It's not known how they act on the brain but the drugs are incredibly popular with students studying for comprehensive exams, shift workers and others who believe they help with concentration and focus.

 Nootropics are including in a ban on "psychoactive substances"

The law, The Psychoactive Substance Act, was designed to stop the import of unstable medications, herbs and other drugs that are used to get a “legal high.” After being approved in Parliament, it took effect in May and companies that had previously carried certain substances had to reorganize their inventories.  The drugs are advertised to otherwise healthy individuals not to treat any specific disease or condition, but to enhance memory, focus and cognitive performance by acting on the brain. Their use is a matter of debate in the neuroscience research community. The law in the UK bans any substance that stimulates or depresses the central nervous system and/or affects mental functioning or emotional state. The Act makes an exception for controlled drugs, medical products, caffeine, nicotine, alcohol and food.
 
The market for these drugs globally is huge. In 2015 approximately $1 billion worth of the supplements and medications were sold. In the United States there are no laws banning their sale and the drugs are a favorite of  Silicon Valley programmers and coders who work long days and nights and believe the drugs help them to focus.
 
Barbara J Sahakian, a professor of clinical neuropsychology in the Department of Psychiatry and Medical Research Council /Wellcome Trust Behavioural and Clinical Neuroscience Institute at the University of Cambridge studies the effects of cognitive enhancing drugs on the brain. In an interview with Sky News she stated, "We could do with better drugs for people who really do have to stay awake and alert, for instance, in the military So long as they are safe in the long-term for healthy people to use, and if they are demonstrated to be effective, that would be good - but we don't have as yet these long-term safety studies.”
 
Many of the nootropic drugs fall into a grey area that some in the UK believe the Psychoactive Substance Act was not designed to cover. While the law will halt or at least reduce drugs like LSD, bath salts, Kratom and other mind altering substances from coming into the UK, substances that are for cognitive enhancement like Adrafinil, Sunifiram and Phenibut are all banned under the act. You can still find drugs such as Kratom for sale. They are meant to promote alertness, improve memory and relax a person during stress. None of these are meant to treat a disease or medical condition but because they act on the brain, the law makes them illegal to import.
 
Part of the backlash against the inclusion of nootropics in the new law was a result of the lack of information that Members of Parliament had about the substances. While there were efforts to make exceptions for nootropics in the law, they were unsuccessful largely because of the in-between area of medical, psychoactive and recreation that some of the substances fall into.
 
For now, citizens in the UK may have to go without their brain enhancing supplements, but with the growth of online retailers in other countries and the fact that enforcement will be difficult, the drugs will likely keep popping up. The video below explains more about nootropics, how they work in the brain and what the UK can expect with the ban.

 
Sources: Inverse, The Kernel

About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
JUL 05, 2021
Cannabis Sciences
Prenatal Cannabis Exposure Lessens Effects of Antidepressants
JUL 05, 2021
Prenatal Cannabis Exposure Lessens Effects of Antidepressants
Researchers at Indiana University have found that mice exposed to cannabinoids while in the womb are less responsive to ...
JUL 05, 2021
Neuroscience
Immature Astrocytes Promote High Levels of Neuroplasticity
JUL 05, 2021
Immature Astrocytes Promote High Levels of Neuroplasticity
Researchers from France have found that astrocytes do more than support neurons in the central nervous system. They foun ...
AUG 17, 2021
Drug Discovery & Development
Severe daytime sleepiness? A new drug can help: FDA approves Xywav to treat idiopathic hypersomnia.
AUG 17, 2021
Severe daytime sleepiness? A new drug can help: FDA approves Xywav to treat idiopathic hypersomnia.
     Being tired throughout the day is a common feeling for most individuals. In fact, 1 out of every 5 A ...
AUG 20, 2021
Technology
"Gamified" Digital Therapeutic Helps Reduce Anxiety
AUG 20, 2021
"Gamified" Digital Therapeutic Helps Reduce Anxiety
Who said games can’t be therapeutic? According to a recent study published in Frontiers in Neurology, a gamified d ...
AUG 24, 2021
Health & Medicine
Do "brain trainers" make you smarter? Maybe, maybe not.
AUG 24, 2021
Do "brain trainers" make you smarter? Maybe, maybe not.
There is no consensus about the efficacy of online cognitive games, but a recent study found no cognitive improvements a ...
SEP 07, 2021
Drug Discovery & Development
A giant step in treating growth disorders in children.
SEP 07, 2021
A giant step in treating growth disorders in children.
Hormone production and release is important in individuals of all ages but is especially important for children as hormo ...
Loading Comments...